Erectile: The Race to Erection - Levitra vs Viagra (cont.)

Levitra is not recommended in patients who have suffered a heart attack or stroke within the last six months, or patients who have significantly low blood pressure, uncontrolled high blood pressure, unstable angina, severe liver impairment, end stage renal disease requiring dialysis, or the eye disorder retinitis pigmentosa.

The most common side effects reported in clinical trials included headache, flushing, rhinitis (runny nose), and indigestion. Dizziness was reported in about 2% of patients. A small number of patients taking Levitra also reported abnormal vision.

Before taking Levitra, patients are advised to undergo a thorough medical history and physical examination to diagnose the underlying cause of the erectile dysfunction and to identify appropriate treatment.

Levitra confers no protection against AIDS or other sexually transmitted diseases.

Levitra is manufactured by Bayer Corporation in Germany and will be distributed by Glaxo Smith Kline. The drug is currently available in Europe.

Based on FDA Talk Paper #T03-63, August 19, 2003 (www.fda.gov)


Last Editorial Review: 7/7/2004